FDA Approves Mitomycin Intravesical Solution for Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

June 12, 2025

For more information, read the FDA announcement and visit the UroGen Pharma website.

Upcoming Events

Oncology

ACCC Leadership Summit

In Person Meeting & NetworkingApril 16, 2026 at 8:00 AM EDT

Express Interest Now!

Oncology

ACCC Oncology Reimbursement Meeting | Charleston

In Person Meeting & NetworkingMay 6, 2026 at 8:00 AM EDT560 King Street, Charleston, SC, USAHyatt Place + Hyatt House Charleston - Historic District, Charleston

Oncology

ACCC Oncology Reimbursement Meeting | St. Louis

In Person Meeting & NetworkingMay 13, 2026 at 8:00 AM CDT1335 South Lindbergh Boulevard, St. Louis, MO, USAHilton St. Louis Frontenac, St. Louis

Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston

Oncology

HSCO 2026 March Dinner Symposium

In Person Conference & ConventionMarch 25, 2026 at 5:30 PM HST3660 Waialae Ave, Honolulu, HI 96816, USA3660 On The Rise, Honolulu

Oncology

LOS 2026 Advocacy Summit

In Person Conference & ConventionApril 1, 2026 at 5:00 PM CDT355 North Boulevard, Baton Rouge, Louisiana, USACity Club of Baton Rouge, Baton Rouge

Oncology

COS 2026 Dinner Symposium - Grand Junction

In Person Conference & ConventionApril 9, 2026 at 6:00 PM MDT840 Kennedy Avenue, Grand Junction, CO, USADevil's Kitchen, Grand Junction

Oncology

TOPS 2026 Annual Conference

In Person Conference & ConventionApril 11, 2026 at 7:00 AM CDT201 8th Avenue South, Nashville, TN 37203, USAJW Marriott Nashville, Nashville

Oncology

MSCO 2026 Spring Conference

In Person Conference & ConventionApril 15, 2026 at 5:00 PM CDTPark Pl Blvd, St. Louis Park, MN, USADoubleTree by Hilton Hotel Minneapolis - Park Place, St. Louis Park

Oncology

KaSCO 2026 Spring Dinner Symposium

In Person Conference & ConventionApril 15, 2026 at 6:00 PM CDT101 W 22nd St, Kansas City, MO, USALidia's Kansas City, Kansas City

Oncology

WVOS 2026 Spring Conference

In Person Conference & ConventionApril 16, 2026 at 8:00 AM EDT200 Lee Street East, Charleston, WV, USACharleston Marriott Town Center, Charleston

FDA Approves Mitomycin Intravesical Solution for Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

Related Content

FDA Approves Teclistamab in Combination With Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma

FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-squamous Non-small Cell Lung Cancer

FDA Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a BRAF V600E Mutation

FDA Approves Acalabrutinib With Venetoclax for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

FDA Approves Novocure’s Optune Pax for the Treatment of Locally Advanced Pancreatic Cancer

FDA Approves Pembrolizumab With Paclitaxel for Platinum-resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Safety Labeling Update for Capecitabine and Fluorouracil on Risks Associated With Dihydropyrimidine Dehydrogenase Deficiency

FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

Upcoming Events

ACCC Leadership Summit

ACCC Oncology Reimbursement Meeting | Charleston

ACCC Oncology Reimbursement Meeting | St. Louis

ACCC 43rd National Oncology Conference

HSCO 2026 March Dinner Symposium

LOS 2026 Advocacy Summit

COS 2026 Dinner Symposium - Grand Junction

TOPS 2026 Annual Conference

MSCO 2026 Spring Conference

KaSCO 2026 Spring Dinner Symposium

WVOS 2026 Spring Conference

Trending Now on
ACCCBuzz Blog

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better Outcomes

From Hospital to Home: A Solution for Proactive Symptom Monitoring and Precise Care

A Candid Conversation About the Power of Early Palliative Care

Rare but Real: Lessons From Providers Treating BPDCN and MCL

Recently Heard on
CANCER BUZZ Podcast

Transforming Palliative Care in Oncology – [Video Podcast] Ep. 227

Streamlining Access to TIL Cell Therapy for Melanoma

Policy in Practice: Change Hits the Clinic – [Podcast] Ep. 225

Addressing Psychosocial Distress With Psychedelic-Inspired Therapies – [Podcast] Ep. 224

Latest from Oncology Issues

Join the Conversation

FDA Approves Mitomycin Intravesical Solution for Recurrent Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

Related Content

FDA Approves Teclistamab in Combination With Daratumumab Hyaluronidase-fihj for Relapsed or Refractory Multiple Myeloma

FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-squamous Non-small Cell Lung Cancer

FDA Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a BRAF V600E Mutation

FDA Approves Acalabrutinib With Venetoclax for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

FDA Approves Novocure’s Optune Pax for the Treatment of Locally Advanced Pancreatic Cancer

FDA Approves Pembrolizumab With Paclitaxel for Platinum-resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Safety Labeling Update for Capecitabine and Fluorouracil on Risks Associated With Dihydropyrimidine Dehydrogenase Deficiency

FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma

Upcoming Events

ACCC Leadership Summit

ACCC Oncology Reimbursement Meeting | Charleston

ACCC Oncology Reimbursement Meeting | St. Louis

ACCC 43rd National Oncology Conference

HSCO 2026 March Dinner Symposium

LOS 2026 Advocacy Summit

COS 2026 Dinner Symposium - Grand Junction

TOPS 2026 Annual Conference

MSCO 2026 Spring Conference

KaSCO 2026 Spring Dinner Symposium

WVOS 2026 Spring Conference

Trending Now on ACCCBuzz Blog

Confronting a Lethal Cancer: Duke Launches Multidisciplinary Pancreatic Cancer Center for Earlier Detection and Better Outcomes

From Hospital to Home: A Solution for Proactive Symptom Monitoring and Precise Care

A Candid Conversation About the Power of Early Palliative Care

Rare but Real: Lessons From Providers Treating BPDCN and MCL

Recently Heard on CANCER BUZZ Podcast

Transforming Palliative Care in Oncology – [Video Podcast] Ep. 227

Streamlining Access to TIL Cell Therapy for Melanoma

Policy in Practice: Change Hits the Clinic – [Podcast] Ep. 225

Addressing Psychosocial Distress With Psychedelic-Inspired Therapies – [Podcast] Ep. 224

Latest from Oncology Issues

Join the Conversation

Trending Now on
ACCCBuzz Blog

Recently Heard on
CANCER BUZZ Podcast